FI845061L - Foerfarande och produkter foer paovisande av humant t-celleukemivirus. - Google Patents

Foerfarande och produkter foer paovisande av humant t-celleukemivirus.

Info

Publication number
FI845061L
FI845061L FI845061A FI845061A FI845061L FI 845061 L FI845061 L FI 845061L FI 845061 A FI845061 A FI 845061A FI 845061 A FI845061 A FI 845061A FI 845061 L FI845061 L FI 845061L
Authority
FI
Finland
Prior art keywords
celleukemivirus
humant
glycoprotein
foerfarande och
paovisande
Prior art date
Application number
FI845061A
Other languages
English (en)
Other versions
FI89175C (fi
FI89175B (fi
FI845061A0 (fi
Inventor
Myron E Essex
Tun-Hou Lee
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23942758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI845061(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College filed Critical Harvard College
Publication of FI845061L publication Critical patent/FI845061L/fi
Publication of FI845061A0 publication Critical patent/FI845061A0/fi
Application granted granted Critical
Publication of FI89175B publication Critical patent/FI89175B/fi
Publication of FI89175C publication Critical patent/FI89175C/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI845061A 1983-04-27 1984-12-20 Foerfarande och produkter foer paovisande av humant t-celleukemivirus FI89175C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48918783A 1983-04-27 1983-04-27
US48918783 1983-04-27
PCT/US1984/000561 WO1984004327A1 (en) 1983-04-27 1984-04-13 Method and products for detection of human t cell leukemia virus
US8400561 1984-04-13

Publications (4)

Publication Number Publication Date
FI845061L true FI845061L (fi) 1984-12-20
FI845061A0 FI845061A0 (fi) 1984-12-20
FI89175B FI89175B (fi) 1993-05-14
FI89175C FI89175C (fi) 1993-08-25

Family

ID=23942758

Family Applications (1)

Application Number Title Priority Date Filing Date
FI845061A FI89175C (fi) 1983-04-27 1984-12-20 Foerfarande och produkter foer paovisande av humant t-celleukemivirus

Country Status (7)

Country Link
EP (1) EP0151579B1 (fi)
JP (1) JP2780020B2 (fi)
AT (1) ATE127517T1 (fi)
AU (1) AU583473B2 (fi)
DE (1) DE3486404T2 (fi)
FI (1) FI89175C (fi)
WO (1) WO1984004327A1 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS6044870A (ja) * 1983-08-22 1985-03-11 Fujirebio Inc 成人ｔ細胞白血病ウイルス抗体検出用試薬
US7232654B1 (en) 1983-09-15 2007-06-19 Institut Pasteur DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1)
GB8423659D0 (en) 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
US7205102B1 (en) 1983-09-15 2007-04-17 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA
GB8429099D0 (en) 1984-11-16 1984-12-27 Pasteur Institut Closed dna sequences
JPS6061534A (ja) * 1983-09-16 1985-04-09 Kyowa Hakko Kogyo Co Ltd 成人ｔ細胞白血病ウイルス抗原ペプチド
US5053224A (en) * 1983-11-07 1991-10-01 Hilary Koprowski Induction of antibody response to solid tumors with anti-idiotype antibodies
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
US7351412B1 (en) 1983-12-05 2008-04-01 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA
US5610035A (en) * 1983-12-05 1997-03-11 Institut Pasteur Centre National De La Recherche Scientific Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies
EP0152030A3 (en) * 1984-02-03 1986-08-13 Juridical Foundation Japanese Foundation for Cancer Research Adult t cell leukemia virus antigen polypeptide
US4724258A (en) * 1984-02-03 1988-02-09 Juridical Foundation, Japanese Foundation For Cancer Research Adult T cell leukemia virus antigen polypeptide
KR930000189B1 (ko) * 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
US5705612A (en) 1984-10-18 1998-01-06 Institut Pasteur And Centre National De La Recherche Scientifique NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)
US7045130B1 (en) 1984-10-18 2006-05-16 Institut Pasteur Antibodies against antigens of human immunodeficiency virus (HIV-1)
US6894152B1 (en) 1984-11-16 2005-05-17 Institut Pasteur Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA
EP0203177A4 (en) * 1984-11-29 1987-04-28 Scripps Clinic Res POLYPEPTIDES AND ANTIBODIES AGAINST DEGGLYCOSILIZED VIRAL GLYCOPROTEINS.
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
US5773210A (en) * 1985-04-19 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
AU592142B2 (en) 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US5364933A (en) * 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
FR2595826B1 (fr) * 1986-03-13 1990-09-07 Lurhuma Zirimwabagabo Produit d'immuno-essai, son procede de preparation, son utilisation, complexe immunogene le comportant et utilisation de ce complexe
DK155886D0 (da) * 1986-04-04 1986-04-04 Bo Arne Hofmann Vaccine og fremgangsmaade til fremstilling af denne
DE3784513T2 (de) * 1986-08-04 1993-09-16 Us Commerce Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse.
JP2555117B2 (ja) * 1986-08-11 1996-11-20 アメリカ合衆国 ヒトｂ親リンパ性ウイルス（ｈｂｌｖ）の試験方法
AU615882B2 (en) * 1986-08-12 1991-10-17 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Molecular cloning and clones of human b lymphotropic virus (hblv)
US5286852A (en) * 1988-07-06 1994-02-15 Verigen, Inc. Antibodies specific towards HIV-1 gp 48
WO1990000617A1 (en) * 1988-07-06 1990-01-25 Bio-Research Laboratories, Inc. Antibodies specific towards gp 48

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141783B2 (en) * 1983-11-07 1993-06-16 The Wistar Institute Immune response to tumours and viruses induced by anti-idiotype antibodies
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay

Also Published As

Publication number Publication date
EP0151579A4 (en) 1988-09-28
DE3486404D1 (de) 1995-10-12
EP0151579A1 (en) 1985-08-21
WO1984004327A1 (en) 1984-11-08
ATE127517T1 (de) 1995-09-15
JPS60501179A (ja) 1985-07-25
FI89175C (fi) 1993-08-25
DE3486404T2 (de) 1996-02-01
EP0151579B1 (en) 1995-09-06
AU583473B2 (en) 1989-05-04
FI89175B (fi) 1993-05-14
JP2780020B2 (ja) 1998-07-23
AU2826184A (en) 1984-11-19
FI845061A0 (fi) 1984-12-20

Similar Documents

Publication Publication Date Title
FI845061L (fi) Foerfarande och produkter foer paovisande av humant t-celleukemivirus.
DE3587969D1 (de) Testverfahren zum nachweis von menschlichem lymphotropischem virus.
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
DE69027812D1 (de) Verfahren zur Zurichtung eines verbesserten Western-Blott-Immuntestverfahrens
ES2080099T3 (es) Ensayo para la hepatitis c.
KR920701481A (ko) 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프
SE8900721D0 (sv) Methods for detection of antibodies to
ES2133269T3 (es) Gen receptor del factor de crecimiento derivado de plaquetas de tipo oc.
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
GR1000033B (el) Δοκιμασια για την ανιχνευση αντιγονων ηπατιτιδας και αντισωματων aids.
FI922666A0 (fi) Diagnostiskt foerfarande.
SE8900899L (sv) Peptider foer diagnostisk anvaendning
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
WO1987007647A1 (en) Method for detection of antibodies to htlv-iii virus and diagnostic test kit useful therewith
DK0491713T3 (da) Rubella El-peptider og C-peptider
SE8704765L (sv) Immunologiskt aktiva polypeptider, anvendbara for framstellning av antimalariavacciner och diagnostest for pavisande av antisporozoantikroppar
Scalarone Use of a urease-antibody conjugate in an enzyme immunoassay for the detection of blastomycosis
Cox et al. Simple diagnostic test for antibodies to Encephalitozoon cuniculi based on enzyme immunoassay
NO165128C (no) Fremgangsmaate for eliminering av falske positive resultater fra systemiske lupuserythematodes-pasienter ved bestemmelse av et atl-virusantistoff i en testproeve.
SE9101863D0 (sv) Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
DK619984A (da) Fremgangsmaade og produkter til detektering af humant t-celleleukaemivirus
KR860004314A (ko) 단순헤르페스 바이러스 항체의 측정방법
ES2019573A4 (es) Inmunoensayo para la deteccion de (alfa)-haloacetamidas.
ES2163411T3 (es) Metodo para la identificacion de individuos infectados con vih y supervision de su terapia.

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired

Owner name: PRESIDENT AND FELLOWS OF HARVARD COLLEGE